BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  IRLAB Publishes Interim Report for the Period January - March 2025

  May 7, 2025

   · 

  9 min read
• Press Releases

  Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis

  May 7, 2025

   · 

  5 min read
• Press Releases

  The world’s first: Grand Pharma’s global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China

  May 7, 2025

   · 

  6 min read
• Press Releases

  Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

  May 7, 2025

   · 

  4 min read
• Press Releases

  Yaqrit’s HE candidates set for phase 3 as company shows underpinning data at EASL

  May 7, 2025

   · 

  4 min read
• Press Releases

  Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

  May 7, 2025

   · 

  1 min read
• Press Releases

  Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025

  May 7, 2025

   · 

  3 min read
• Press Releases

  Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress

  May 7, 2025

   · 

  7 min read
• Press Releases

  Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US

  May 7, 2025

   · 

  7 min read
• Press Releases

  Candel Therapeutics to Present at Upcoming Investor Conferences - May 6, 2025

  May 7, 2025

   · 

  4 min read